 Gossip Jackal |
FDA Panel Rejects Vivus Weight-Loss Drug Qnexa
Wall Street Journal Most panel members were also part of the Avandia panel that met earlier this week to discuss whether to keep that drug on the market amid concerns that the … Arena Pharma Rallies On FDA Optimism; Vivus Shares Halted Vivus' Qnexa takes center stage during panel review 3 New Weight Loss Drugs Waiting for FDA OKs |
Avandia Lawsuit | Avandia Lawsuits
Legal Information For Free
